-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
png">
png">
PD-1 inhibitors can restore the vitality of bioon.
bioon.
bioon.
bioon.
The researchers observed that PD-1AB21 completely blocked the binding of PD-L1IgFc after binding to EG7 lymphoma cells expressing PD-1 and activated CD8+ T cells.
This indicates that PD-1AB21 can bind to PD-1 on activated T cells, blocking the interaction of PD-1 and PD-L1, while maintaining the biological activity of IL-21.
After in-depth exploration, the researchers found that PD-1Ab21 can target IL-21 to activated T cells, and compared to recombinant IL-21, it can more effectively induce activated CD8+ T cells to differentiate into TSCM cells (memory stem T cells).
TSCM cells have strong proliferation potential, long-term survival ability and the ability to generate all memory and effector T cell subsets after exposure to antigen.
Tumor-bearing mice showed an increase in the frequency of TSCM and a large number of tumor-specific memory T cells after PD-1AB21 treatment, and the anti- bioon.
bioon.
bioon.
bioon.